Search results
Results from the Tech24 Deals Content Network
Analysts were expecting a profit of $10.36 per share for the year, according to LSEG data. On an adjusted basis, Stryker reported a profit of $2.46 per share for the quarter ended Sept. 30 ...
The joint-implant maker raised the lower end of its profit forecast to $10.35 from 10.25 per share, while keeping the top-end of the range unchanged at $10.45. The company also beat Wall Street ...
In the second quarter, sales at Stryker's medical surgery and neurotechnology unit rose 12.2%, to $2.9 billion, while sales in the orthopedics and spine segment rose nearly 10%, to $2.
US$18.6 billion (2023) [1] Number of employees. 52,000 (2023) [1] Website. stryker .com. Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. [2] Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems ...
From September 4, 2007 to September 9, 2008 he was the on-stage DJ for the 5th season of The Ellen DeGeneres Show. Stryker voiced himself as the in-game radio disc jockey in Burnout 3: Takedown. He has also hosted shows on MTV, Fox Sports, VH1, Fuse and Direct TV and has acted in several feature films, including Grandma's Boy, Out Cold and The ...
Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now sees its annual profit per share ...
MAKO Surgical was founded in 2004 by Rony Abovitz and other key members of its predecessor Z-KAT, Inc. Z-KAT was founded in 1997 by Rony Abovitz, William Tapia, Michael Peshkin Ph.D., Julio Santos-Munne, and Wayne J. Kerness, M.D. and was developing a novel haptic robotic system for medical applications, amongst a wide variety of computer-assisted surgery technologies.
In the second-quarter report, Intel reported a 1% decline in revenue to $12.8 billion and adjusted earnings per share of $0.02 -- both of these missing analysts' estimates.